Daniel S Peeper

25PUBLICATIONS
126CO-AUTHORS
Molecular targetsHaematological tumoursTumour immunologyCellular immunologyFood engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Mar 11, 2026
Targeting the Non-Homologous End Joining Pathway Sensitizes MDM2-Amplified Liposarcoma to Doxorubicin by Enhancing p53-Mediated Senescence.

Thijs Jalving, Carine Dufau, Juan Simon Nieto

|Nov 28, 2025
Inhibition of TBK1/IKKε mediated RIPK1 phosphorylation sensitizes tumors to immune cell killing.

Anastasia Piskopou, David W Vredevoogd, Xiangjun Kong

|Nov 28, 2025
Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?

Daphne van der Geest, Alex van Vliet, Daniel S Peeper

|Nov 19, 2025
Tumour-reactive heterotypic CD8 T cell clusters from clinical samples.

Sofía Ibáñez-Molero, Johanna Veldman, Juan Simon Nieto

|Jul 04, 2025
Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers.

Tim Arnoldus, Alex van Vliet, Onno B Bleijerveld

|Jan 21, 2025
TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors.

Jennifer Wagner, David Vredevoogd, Xin Yu

Pageof 5

Frequent Collaborators

7 joint publications

Christian U Blank

6 joint publications

David W Vredevoogd

5 joint publications

Onno B Bleijerveld

4 joint publications

John B A G Haanen